Jul 28, 2025 11:00
PMN - ProMIS Neurosciences Inc. Common Shares (ON)
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
0.47 0.01 (1.64%) | --- | 0.0 (0.0%) | 0.0 (0.0%) | 0.01 (2.35%) | -0.02 (-4.17%) | 0.01 (1.97%) | 0.01 (1.97%) |
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -0.21
- Diluted EPS:
- -0.21
- Basic P/E:
- -2.27
- Diluted P/E:
- -2.27
- RSI(14) 1m:
- 100.0
- VWAP:
- 0.48
- RVol:
Events
Period | Kind | Movement | Occurred At |
---|
Related News
Feb 13, 2025 18:00
Jul 26, 2024 12:35
May 14, 2024 20:01
Apr 15, 2024 18:11
Apr 15, 2024 14:00
Apr 01, 2024 20:15
Feb 22, 2024 12:00
Jan 22, 2024 12:00
Jan 19, 2024 18:05